Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

ORNL joins global fight against polio

By Drug Discovery Trends Editor | October 17, 2014

The new Urban Dynamics Institute at the U.S. Dept. of Energy (DOE)’s Oak Ridge National Laboratory (ORNL) is working with the Bill & Melinda Gates Foundation to aid polio vaccination efforts in developing countries.

Teams at the institute will apply big data analysis to population dynamics in Nigeria, allowing polio vaccination crews to better estimate the amount of vaccine needed and to target areas of priority, saving time and money in eradicating the disease.

Founded this year, the Urban Dynamics Institute brings together ORNL scientists across disciplines to explore the interaction between people and the urban environment, and the impacts of land use, energy, transportation and more. ORNL is home to Titan, the second-most-powerful computer in the world, allowing researchers to analyze and draw conclusions from massive amounts of information.

“One of our key focuses is to understand global population distributions and the movement of populations to urban areas in the changing urban landscape,” said the institute’s founding director, Budhendra Bhaduri.

“The polio eradication program targets children primarily under the age of five for vaccination, and you need an understanding of where people are and what percentage of the population could be five or younger for making the campaign efficient and successful.”

Since the World Health Assembly announced the goal of eradicating polio in 1988, the number of polio cases has fallen by more than 99%, with the disease remaining endemic in only three countries: Afghanistan, Pakistan and Nigeria. One problem faced by polio vaccination teams in these countries, however, is the lack of accessible and reliable population and settlement data, which makes strategizing vaccine operations increasingly difficult.

“If you don’t know where people are, you can’t be effectively reaching everybody,” Bhaduri said.

The data collected and assessed by the Urban Dynamics Institute will help polio vaccination teams focus their efforts in Nigeria, and contribute to the goal of the Global Polio Eradication Initiative to eradicate polio worldwide. The Global Polio Eradication Initiative is a partnership of the World Health Organization, UNICEF, the Centers for Disease Control and Rotary International supported by the Bill & Melinda Gates Foundation.

Source: Oak Ridge National Laboratory


Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE